1. Home
  2. DVA vs HTHT Comparison

DVA vs HTHT Comparison

Compare DVA & HTHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • HTHT
  • Stock Information
  • Founded
  • DVA 1994
  • HTHT 2005
  • Country
  • DVA United States
  • HTHT China
  • Employees
  • DVA N/A
  • HTHT N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • HTHT Hotels/Resorts
  • Sector
  • DVA Health Care
  • HTHT Consumer Discretionary
  • Exchange
  • DVA Nasdaq
  • HTHT Nasdaq
  • Market Cap
  • DVA 10.9B
  • HTHT 10.9B
  • IPO Year
  • DVA 1995
  • HTHT 2010
  • Fundamental
  • Price
  • DVA $142.56
  • HTHT $33.23
  • Analyst Decision
  • DVA Hold
  • HTHT Strong Buy
  • Analyst Count
  • DVA 4
  • HTHT 2
  • Target Price
  • DVA $157.00
  • HTHT $45.00
  • AVG Volume (30 Days)
  • DVA 857.4K
  • HTHT 1.3M
  • Earning Date
  • DVA 08-05-2025
  • HTHT 08-19-2025
  • Dividend Yield
  • DVA N/A
  • HTHT 5.84%
  • EPS Growth
  • DVA 14.90
  • HTHT N/A
  • EPS
  • DVA 10.11
  • HTHT 1.42
  • Revenue
  • DVA $12,968,524,000.00
  • HTHT $3,308,482,052.00
  • Revenue This Year
  • DVA $6.46
  • HTHT $7.30
  • Revenue Next Year
  • DVA $3.24
  • HTHT $8.21
  • P/E Ratio
  • DVA $14.10
  • HTHT $23.36
  • Revenue Growth
  • DVA 5.11
  • HTHT 5.86
  • 52 Week Low
  • DVA $131.76
  • HTHT $27.03
  • 52 Week High
  • DVA $179.60
  • HTHT $42.98
  • Technical
  • Relative Strength Index (RSI)
  • DVA 55.72
  • HTHT 38.15
  • Support Level
  • DVA $135.07
  • HTHT $33.06
  • Resistance Level
  • DVA $147.45
  • HTHT $34.06
  • Average True Range (ATR)
  • DVA 3.05
  • HTHT 0.87
  • MACD
  • DVA 0.82
  • HTHT -0.04
  • Stochastic Oscillator
  • DVA 61.83
  • HTHT 21.05

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About HTHT H World Group Limited

H World Group Ltd is a multi-brand hotel group in China with international operations. It operates in the leased, manachised, and franchised models. The company has two operating segments; legacy Huazhu and legacy DH. Its brand and product offering includes Economy hotel brands: HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, and Ibis Hotel, Midscale hotel brands: JI Hotel, Orange Hotel, Starway Hotel and Ibis Styles Hotel, Upper midscale hotel brands: Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, CitiGO Hotel and MAXX by Steigenberger, Upscale hotel brands: Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, Jaz in the City, and Grand Mercure; and Luxury hotel brand: Steigenberger Icon and Song Hotels.

Share on Social Networks: